Robert William Altrich, in Colorado Springs, CO - Medicare Physician Assistant

Robert William Altrich, is a medicare enrolled "Physician Assistant" physician in Colorado Springs, Colorado. His current practice location is 10807 New Allegiance Dr Ste 160, Colorado Springs, Colorado. You can reach out to his office (for appointments etc.) via phone at (720) 749-5599.

Robert William Altrich is licensed to practice in Colorado (license number PA.0008285) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1265212906.

Contact Information

	Robert William Altrich,
	10807 New Allegiance Dr Ste 160, Colorado Springs, CO 80921-3805
	(720) 749-5599
	(720) 925-5897

Physician's Profile

Full Name	Robert William Altrich
Gender	Male
Speciality	Physician Assistant
Location	10807 New Allegiance Dr Ste 160, Colorado Springs, Colorado
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1265212906
Provider Enumeration Date: 10/02/2023
Last Update Date: 03/08/2024

Medicare PECOS Information:

PECOS PAC ID: 2466898960
Enrollment ID: I20240306003619

Medical Identifiers

Medical identifiers for Robert William Altrich such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1265212906	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208VP0000X	Pain Medicine - Pain Medicine	PA.0008285 (Colorado)	Secondary
363A00000X	Physician Assistant	PA.0008285 (Colorado)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Robert William Altrich is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Robert William Altrich, 5445 Dtc Pkwy Ste 1130, Greenwood Village, CO 80111-3038 Ph: (720) 749-5599	Robert William Altrich, 10807 New Allegiance Dr Ste 160, Colorado Springs, CO 80921-3805 Ph: (720) 749-5599

News Archive

Stem cells derived from human amniotic fluid appear to offer many of the benefits of embryonic stem cells

...including the ability to grow into brain, muscle, bone and other tissues - according to a study published in the Jan. 7 online edition on the journal Nature Biotechnology, the Washington Post reports.

International Institute of Biomedical Sciences and Technology established for a global research initiative

Upstate Medical University in Syracuse, New York, the Technion-Israel Institute of Technology in Haifa, Israel, and National Cheng Kung University in Tainan City, Taiwan, have announced the creation of the International Institute of Biomedical Sciences and Technology that will facilitate the collaboration of research across three continents and accelerate the development of novel bioengineering, diagnostic and biomedical products for the treatment and cure of disease, officials said today.

Zogenix, Desitin receive MAA approval for SUMAVEL DosePro in Germany and the UK

Aradigm Corporation today announced that Zogenix, Inc. and Desitin Pharmaceuticals GmbH were granted approval of the Marketing Authorization Application for SUMAVEL® DosePro™ (sumatriptan injection) needle-free delivery system for the acute treatment of migraine attacks, with or without aura, and the acute treatment of cluster headache by the Federal Institute for Drugs and Medical Devices of Germany (BrArM) and the Medicines and Healthcare products Regulatory Agency of the United Kingdom (MHRA).

Scientists develop new experimental diagnostic test to distinguish infection from disease

A potential new experimental diagnostic test able to quickly distinguish individuals with active tuberculosis from those with latent TB infection has been developed. If the preliminary results of the study will be confirmed in a larger population sample, the new diagnostic system could allow more effective strategies to control the spread of the re-emerging pathology.

UCLA pediatric investigators earn top accolades at TTCF Faculty Presentation Awards

A new therapy for type 1 diabetes? A promising treatment for deadly viruses? Does a common treatment for children with severe infection actually cause more harm than good? These are important questions being investigated by pediatric researchers at Mattel Children's Hospital UCLA.

Robert William Altrich, - Medicare Physician Assistant in Colorado Springs, CO